Results

MySQUAR - the out of the money warrant exercise that tells you its placing ahoy and this is a slam dunk Norfolk

Published 6 days ago

For the second time in a week we have seen share options exercised at AIM listed Norfolk MySQUAR (MYSQ) - this time it is 1.875 million warrants exercised at 5.5p which will add £103,125 to the coffers. that is kind of handy for this cash guzzler which is close to running on fumes. But this is a spoof.

Monchhichi – hilarious stuff, it’s the old Highlands Natural manoeuvre

Published 39 days ago

I last wrote about Monchhichi (MCC) in February HERE when it completed its underwhelming placing of £2.1 million at the incredible price of 35p and I wondered what it was going to do next. Well, rather than actually invest its funds and generate shareholder value it is has just announced some more financial spoofery last seen at the disastrous Highlands Natural Resources (HNR), It is worth taking a closer look.

Jim Mellon's Diabetic Boot Company spoof unravelling as late accounts filed

Published 42 days ago

I’ve written a few times on the travails of The Diabetic Boot Company over time, usually after yet another Jim Mellon-related company lends or invests money in this biotech pipedream. Well, its results have finally come out, two months late, and they make interesting reading.

BOS Global: Fair play – some answers provided and the Call Design spoof clarified

Published 43 days ago

I wrote last week (HERE) about the disappointing opaque nature of some of the recent announcements emanating from BOS Global (BOS) and raised a number of questions that were bothering me. To give the company some credit, it has issued two RNS’s since then clarifying certain aspects and particularly pleased with the clarity on the Call Design deal.

Advanced Oncotherapy – another day, another spoof? Spot the missing statement....

Published 76 days ago

Advanced Oncotherapy (AVO) has announced that NED and highly respected senior clinical oncologist at Great Ormond St and Barts Dr Nick Plowman “will” invest £250,000 in the company – at 30p a share, a 36% premium to last week’s close. Why am I not convinced that this morning’s announcement is anything other than the most desperate of spoofs in a long line of spoofs here?

Advanced Oncotherapy – another spoof from the kings of spoofery as this time Exec Chairman buys

Published 87 days ago

Well that explains it then! Yesterday I noted my amazement that AIM-listed Advanced Oncotherapy (AVO) had issued yet another ramparoonie director share purchase RNS on Tuesday and that the shares had raced back above not only the all-important 27.5p mark, but above 30p. Now we know why: Executive Chairman Dr Michael Sinclair was in the market filling his boots with 200,000 shares  at an average price of 30.44p. Shame he didn’t pile in when the shares were hovering around the 26p mark so as to save himself a few quid.

Advanced Oncotherapy – more spoofery as NED buys yet more shares

Published 89 days ago

AIM-listed Advanced Oncotherapy (AVO) – teetering on the brink of having to call an EGM to reduce its nominal share capital under the terms of its death-spiral funding package with Bracknor – has announced yet another director share purchase, the fourth just this month (if we ignore the botched 7am RNS of 4 April). As ever, this is just a spoof in order to encourage more buying in the market so as to allow Bracknor to offload more of its death-spiral conversion shares as Advanced hopes and prays for the next £1.235 million tranche of funding before the coffers run dry.

Advanced Oncotherapy – SPOOF, SPOOF AND SPOOF some more

Published 101 days ago

Under its death spiral funding package with Bracknor, AIM-listed Advanced Oncotherapy (AVO) has to call an EGM to seek shareholder approval to reduce the nominal price of its shares (currently 25p) by at least half if the closing share price is below 110% of nominal (ie 27.5p) for ten consecutive trading days. And that brings us to the latest spoof director share purchase announced this morning (which hasn’t worked: the shares are down 4% last seen this morning).

Boxhill Technologies: Another dodgy-looking deal – when will Allenby resign?

Published 103 days ago

Following the profit warning and announcement of the forthcoming Timegrand deal back in February that I covered HERE, Boxhill Technologies (BOX) announced the completion of that deal late yesterday afternoon. Unsurprisingly, the deal raises more questions than it answers and I’m beginning to wonder when Allenby will say enough is enough. Let’s take a closer look at the RNS.

Advanced Oncotherapy – another SPOOOOOOOOOF and a screwed up RNS: KEEP SELLING

Published 109 days ago

It seems that AIM-listed Advanced Oncotherapy (AVO) is so desperate to get out any good news it can that it rushed out an RNS yesterday morning to notify the market of director buying and got the numbers wrong. Oops. Great work in checking and verifying there by Nomad Stockdale Securities.

Sepura – Hmmm, was that RNS really about “Competition approvals”?

Published 114 days ago

It’s been an absolute roller-coaster of a week for Sepura (SEPU) which is embroiled in a drawn-out takeover saga with Hytera Communications subject to competition delays. There were a number of interesting RNS’s worth commenting on this week but one in particular has my spoof antennae whirring. Were shareholders being told the whole story?

Servision – Hurrah! A TR-1 from Cascade. But if it walks like a spoof and quacks like a spoof…..

Published 116 days ago

So after all the questions, AIM-listed Servision (SEV) has provided answers. The AIM Rule 26 pages have been updated (after a year, vs 6-months under AIM rules), the personal guarantee of head honcho Gidon Tahan to white knight investors Cascade has been clarified and yesterday lunchtime we even had a TR-1 showing that Cascade was indeed holding the shares issued to it at over 400% of the previously prevailing share price ahead of the announcement of the funding package. But I still think the whole deal is a massive spoof and here is why.

Frontera – well ahead of itself, sell

Published 122 days ago

One has to marvel at how oily serial disappointment AIM-listed Frontera (FRR) has doubled its share price since yesterday. Has it has a takeover? Nope. Has it announced a gusher? Nope. So what has sparked the rise? It seems  that it is in talks over a possible transaction involving a farm-out or joint operation arrangement within the area of its Block 12 holding in Georgia. But is this just a monster spoof?

BOS Global – My biggest AIM bugbear: the share price spoof

Published 124 days ago

I haven’t been following BOS Global (BOS) that closely since the comedy gold video I commented on HERE but note the share price has increased quite nicely in recent months, much to my surprise. I noted, however, an acquisition announced yesterday which included the one thing that annoys me more than any other on AIM, the spoof made-up share price for equity issued as consideration for acquisitions. Let me explain.

Is Bracknor spoofing investors to postpone the collapse of the Advanced Oncotherapy death spiral?

Published 125 days ago

Death spiral provider Bracknor does not buy shares in companies. It loans the desperate, cash at pound of flesh rates which it then converts into shares at discounted rates and flogs to mug punters. That is the classic death spiral model. But to get such a death spiral away it needs a perception of market liquidity and also to avoid a complete short term collapse of the share price. And that brings us to Advanced Oncotherapy (AVO).

Tom Winnifrith Bearcast - Extreme Bad Language Special because AIM is an ffing joke

Published 138 days ago

If you object to bad language do not listen. The madness and corruption of AIM, the willingness of the crony capitalists to deceive investors to get away another placing just got to me. In today's podcast I cover Blur (BLUR) - but would commend young Steve's coverage which is superb HERE, FastForward (FFWD) - the Jim Mellon spoof - Advanced Oncotherapy (DOG), Independent Resources (IRG), Amur Minerals (AMC), Sunrise Resources (SRES) and Zenith Energy (ZEN). 

Eden Research – The art of value creation. How a licence worth only £20,000 in June 2013 became worth £600,000 in August 2015.

Published 138 days ago

On 24 August 2015, Eden Research (EDEN) announced its now infamous deal (aka massive panama pump fraud) with TerpeneTech. That fraud is now unravelling big time as explained here. But let us revert to the RNS of 2015 which stated : 

Craven House Capital – Well, you can’t say that you haven’t been warned!

Published 230 days ago

After nine months of scratching my head, I had a lightbulb moment this morning and have finally reached a conclusion as to what is really going on at the “investment company”, Craven House Capital (CRV). The short answer, for those that struggle to get through a thousand words, is that it is totally uninvestable for the private investor, but the most interesting part of it is that the company knows that and it is pretty open about telling its shareholders that that is the case. Whether they listen or not is another matter!

Fastjet – unusual warrant exercises = spoofery, signs of a cash crunch or just madness?

Published 260 days ago

As AIM-listed crock airline Fastjet (FJET) hurtles at full speed towards its next funding crisis two warrant exercises catch the eye – one yesterday and the other last week. With the shares trading at around 20p, why on earth would anyone exercise warrants at 31.5p a pop?

Life Science Developments – the interesting case of The Diabetic Boot Company (Part 2): The Jim Mellon spoof

Published 290 days ago

I almost spat out my cornflakes with laughter at the ridiculous announcement from Life Science Developments (LIFE) this morning as it entered suspension pending an RTO with The Diabetic Boot Company (“DBC”). Please allow me to explain.

Craven House Capital – More ridiculous deals that raise more questions than answers

Published 306 days ago

As Levrett (LVRT), that I commented on earlier, has got my blood boiling slightly, I need to get a few more matters off my chest relating to the oddest investment company on the London market, namely Craven House Capital (CRV) and its two most recent investments.

Craven House Capital: the spoof investment company without a home to go to

Published 360 days ago

Disappointing news emanating from Craven House Capital (CRV) at 11.20am today calling off the exciting move to the Specialist Fund Segment of the Main Market as it failed the eligibility criteria, so where does this leave the company now?

President Energy (oink, oink) – Placing ahoy?

Published 366 days ago

I see that AIM-listed President Energy (PPC) has this morning announced the appointment of a new joint broker in the form of BMO Capital Markets Ltd. One’s suspicions are, of course, immediately raised: an energy company (hardly a happy sector at the moment) appointing a new broker? Is it placing ahoy?

Highlands Natural - will we see the TR1 today or is your spoofing about to emerge

Published 380 days ago

If one takes a disclosable stake in a listed company you must notify the company within five working days and it must by the close of the next working day, notify the market. So we should be seeing a TR1 from Highlands Natural Resources (HNR) today then. If we do not then investors have been spoofed.

Craven House Capital: the astonishing RNS’s continue – now raising a further $150m - REALLY!

Published 390 days ago

I have a simple rule when it comes to AIM investing. If I cannot fathom what is happening, then I stay clear and Craven House Capital (CRV), that I have covered a number of times HERE, is a great example as it has issued yet another RNS that leaves me equally astonished and baffled.

Tom Winnifrith Bearcast: Go ahead start sacking the investment bankers, I'd pay to watch

Published 392 days ago

No lightning strikes today, thank God. What was he punishing me for? I start by discussing Richard Poulden's excellent letter on why folks are so angry so backed Brexit, but it is a wider issue as you can read here. Then I discuss liquidity in an investment company's portfolio, ref Teathers Financial (TEA) and finally I challenge the banks to make good their Brexit threat to fire investment banksters. I will pay for a ticket to watch but I explain why it was always a spoof. It won't happen.

Shanta Gold – another spoof director share buy

Published 404 days ago

AIM-listed Shanta Gold (SHG) has announced another director share purchase which looks to me to be more of a sell signal than a buy signal. I previously highlighted (HERE) that CEO Toby Bradbury had changed his mind about supporting the recent fundraising by ponying up for 500,000 shares at the offer price of 6.5p – instead completing half of promised purchase in the market at the reduced price of 5.65p. Today we learn that NED Robin Fryer has put his hand in his pocket to the tune of 45,000 shares at 6.2p.

Shanta Gold - Director buy SPOOF!!

Published 423 days ago

As much as it pains me to highlight this, as I hold a (very) small handful of shares here, I note with interest an announcement at 4.17pm yesterday afternoon (almost no-one-is-watching o'clock) from AIM-listed Shanta Gold (SHG) which simply strikes me as a spoof. It is a director buy, but I fear that it is a sell signal. Here is why.

Craven House Capital – the spoof continues…..but who ponied up £3.5 million?

Published 431 days ago

Having written a series of pieces earlier in the year on Craven House Capital (CRV) detailing various reasons as to why I perceived to be an almighty spoof (HERE), I am part astounded and part confused by yesterday’s placing announcement at a massive premium to the share price.

Spoof, spoof, spoof - Mark Gustafson buys more Challenger shares: KEEP SELLING

Published 433 days ago

I explained on the previous occasion that Mark Gustafson, the CEO of Challenger Acquisitions (CHAL) announced that he had bought lots of shares that he was spoofing. Now he is at it again but it even the dumbest moron must now realise the spoof is not working.

Challenger Acquisitions CEO Mark Gustafson tries to play spoof - it is not working

Published 440 days ago

Another day and its another announcement from Challenger Acquisitions (CHAL) that its boss is again buying shares. Don't be fooled this is a spoof. Its a sell signal not a sign to buy.

Tom Winnifrith Bearcast 5 May - the Great LGO Spoof worked! Well for now anyway!

Published 444 days ago

In reflective mood on election day I cover just a few companies. Falanx (FLX) where we backed the placing and the shares have tanked! LGO Energy (LGO) where the morons were spoofed and death is postponed, Centrica where shareholders are paying for CEO crack, that is debt addiction and  Feedback (FDBK) which seems like a rum and coke to me. I also cover, en passant, Conroy after getting a pleasant ambush, but an ambush none the less, post dentists, from Ireland.

Craven House Capital – An almighty spoof? Part 5: 50 billion shares should be enough!

Published 504 days ago

My final piece on Craven House Capital (CRV), for the moment, looks at the strange goings on in the last couple of months relating to a ridiculous recent increase in the authorised share capital. The full series on Craven House is here.

Craven House Capital – An almighty spoof? Part 4: What happened to The Bicycle Company?

Published 504 days ago

Continuing my series on Craven House Capital (CRV) and Tom’s look at the Pressfit deal, I’ve taken a closer look at their its most valuable single investment  - The Bicycle Company. The full series on Craven House is here.

Craven House Capital – An almighty spoof? Part 3: Is that GEM really worth $30m?

Published 507 days ago

My series on Craven House Capital’s (CRV) appalling behaviour in RNS’s continues with one of the more recent spoofs, namely the potential investment by GEM Global Yield Fund of up to $30m.

Craven House Capital – An almighty spoof? Part 2: Let’s take a closer look at the investment accounting

Published 507 days ago

Having got enraged over something admittedly rather minor in Craven House Capital’s (CRV) interims, I started looking at detail at the various investments and the absurd accounting of each one.

Craven House Capital – An almighty spoof? Part 1: Here are the highlights

Published 507 days ago

I accept that I woke up in a bad mood on Monday; however, one ridiculous comment in Craven House Capital’s (CRV) interims RNS got my back up even more and lead me to investigating further. I’ve been pulling on that investigative thread ever since so thought I’d write a series of articles on what appears to me to be one almighty spoof.

Independent Resources - Shareholders ARE mugged as we warned: FCA MUST Investigate

Published 513 days ago

We warned you two days ago that Independent Resources (IRG) was trying to spoof investors with a bogus announcement in order to get a discounted placing away...it has not taken long, the placing today is a shocker. the FCA and AIM Regulation must investigate.

Independent Resources - you are being spoofed, do not fall for this trick

Published 515 days ago

Independent Resoures (IRG) is almost bust and will do a placing to keep the lights on very soon. But its shares are up by 185% today at 0.3p thanks to an RNS which is a spoof aimed at fooling mug punters. It has worked, never underestimate the stupidity of AIM investors.

Golden Saint Resources Live Execution Day 9 – Gollum covers up how investors spoofed

Published 644 days ago

It goes without saying that there live execution of insolvent AIM listed POS Golden Saint Resources (GSR) via a crowd funded debt death spiral is not going well. The past 24 hours has seen another £0 raised meaning that on day nine net proceeds are still MINUS £1938.50. But an eagle eyed reader has flagged up a weekend change, as CrowdforAngels tries to cover up how investors are being spoofed.

ShareProphets

About ShareProphetsTerms of ServiceForgot My Password
Contact UsPrivacy PolicyForgot My Username
Advertise With UsCookie PolicyResend Account Validation Token
Send Us A Tip

Data by ADVFN / Site by Everywhen /